Generic Name: beractant (ber AK tant)Brand Names: Survanta Intratracheal
Beractant is made from animal lung extract and contains fatty acids and proteins. It works by reducing the surface tension of fluids inside the human lung to keep the lung from collapsing.
Beractant is used to treat or prevent respiratory distress syndrome (RDS) in newborn infants.
Beractant may also be used for purposes other than those listed in this medication guide.
Your child will require special care in the hospital during treatment with beractant. Talk with your doctor about any special instructions for handling the infant and watching for side effects while beractant is given.
Follow your doctor's instructions about any restrictions on feeding or other medications after your child has been treated with beractant.What should I discuss with my health care provider before my child receives beractant?
Your child will require special care in the hospital during treatment for RDS. Talk with your doctor about any special instructions for handling the infant and watching for side effects while beractant is given.
This medication is given through an endotracheal (en-doe-TRAY-kee-al) tube. This is a flexible plastic tube placed in the infant's mouth and passed down into the airway. A doctor will insert the tube using a scope to see the inside of the airway while guiding the tube into place.
Beractant is usually given every 6 hours.
To make sure this medication is helping your child's condition and is not causing any harmful effects, your child's lung function will need to be tested often. This will help your doctor determine how long to continue treatment with beractant. Your child may also need blood tests.
Since beractant is given by healthcare professionals in a hospital setting, it is not likely that your child will miss a dose.
Overdose with beractant has not been reported. Because this medication is given by a healthcare professional, it is not likely that your child will receive an overdose.
Follow your doctor's instructions about any restrictions on feeding or other medications after your child has been treated with beractant.
breathing that stops;
urinating less than usual; or
blood in the urine.
Less serious side effects include:
feeding or bowel problems; or
bleeding around the endotracheal tube.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Pediatric Dose for Respiratory Distress Syndrome:
<48 hours of life: 4 mL/kg instilled intratracheally no more often than every 6 hours for a total of up to 4 doses. For prevention of respiratory distress syndrome in premature infants with birth weights of less than 1750 g and more than 600 g, the first dose is preferably given within 15 minutes of birth. For rescue treatment, the first dose is given as soon as possible, preferably within 8 hours of birth.>48 hours of life: Safety and efficacy have not been established.
There may be other drugs that can interact with beractant. However, your child's care providers will be aware of all medications used in your child's treatment. It is not likely that your child will be given other medications that will interact with beractant.